Alexandre Berda
Director/Board Member at Bugena SA
Network origin in Alexandre Berda first degree
Entity | Entity type | Industry | |
---|---|---|---|
17
| Public Company | Biotechnology | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alexandre Berda via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
CARMAT | Medical Specialties | Founder Chairman | |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Founder Director/Board Member | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Graduate Degree | |
SOLIGENIX, INC. | Pharmaceuticals: Major | Chairman | |
Quethera Ltd.
Quethera Ltd. BiotechnologyHealth Technology Quethera Ltd. develops treatment for eye diseases. It focuses on developing therapies to reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve. The company was founded by Peter Stuart Widdowson and Keith Robert Graham Martin in 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
CLOSE BROTHERS GROUP PLC | Investment Banks/Brokers | Corporate Officer/Principal | |
UNIQURE N.V. | Biotechnology | Founder | |
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | Corporate Officer/Principal | |
C4X DISCOVERY HOLDINGS PLC | Pharmaceuticals: Major | Chief Executive Officer | |
Pathway Biotech Ltd. | Director/Board Member | ||
VERONA PHARMA PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
Ikarovec Ltd.
Ikarovec Ltd. Medical/Nursing ServicesHealth Services Ikarovec Ltd. provides human health care services. The company is headquartered in Canterbury, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Cambridge | College/University | Graduate Degree | |
COMPASS PATHWAYS PLC | Biotechnology | Director of Finance/CFO | |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Marseille | College/University | Doctorate Degree | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bioxodes SA
Bioxodes SA Pharmaceuticals: MajorHealth Technology Bioxodes SA develops pharmaceutical products. Its programme Ir-CPI, is the first in a novel class of antithrombotics, and is developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. The company was founded by Edmond Godfroid and Michel Guyaux on April 20, 2010 and is headquartered in Marche-en-Famenne, Belgium. | Pharmaceuticals: Major | Chairman | |
Syndesi Therapeutics SA
Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Chairman | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director of Finance/CFO | |
Eutelsat, Inc. (United States)
Eutelsat, Inc. (United States) Major TelecommunicationsCommunications Part of Eutelsat Communications SA, Eutelsat, Inc. is a leading satellite operator. The company is based in Washington. The American company's satellite fleet serves broadcasters, telecom operators, ISPs, and government agencies, providing access to millions of homes across various continents. Eutelsat is trusted by leading broadcasters to expand their reach and access new markets. With a powerful fleet of satellites, Eutelsat is launching five new satellites in the next three years. | Major Telecommunications | Chairman | |
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
SGD SA
SGD SA Containers/PackagingProcess Industries SGD SA designs and manufactures glass bottles for the cosmetic and pharmaceutical industries. It offers glass bottles and jars in primary packaging for perfumes and cosmetics, pharmaceuticals, carafes, and glass blocks and insulators. The company was founded 1896 and is headquartered in Paris, France. | Containers/Packaging | Chief Executive Officer | |
EUTELSAT COMMUNICATIONS | Major Telecommunications | Chief Executive Officer | |
Skylogic SpA
Skylogic SpA Specialty TelecommunicationsCommunications Skylogic SpA provides broadband satellite communication services for businesses and public administration. The company is headquartered in Turin, Italy. | Specialty Telecommunications | Director/Board Member | |
Eutelsat Konnect Services SAS | Chairman | ||
Hispasat SA
Hispasat SA Specialty TelecommunicationsCommunications Hispasat SA engages in the provision of satellite communications services. Its service portfolio includes Spanish and Portuguese content through television, and radio channels through its satellite fleet. The company was founded on June 30, 1989 and is headquartered in Madrid, Spain. | Specialty Telecommunications | Director/Board Member | |
Solaris Mobile Ltd.
Solaris Mobile Ltd. Specialty TelecommunicationsCommunications Solaris Mobile Ltd. provides mobile satellite services. It offers terrestrial wireless network infrastructure, manages and provides access to mobile communication networks. The company is headquartered in Dublin, Ireland. | Specialty Telecommunications | Director/Board Member | |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
Ecole Nationale d'Administration | College/University | Masters Business Admin | |
Eutelsat SA
Eutelsat SA Specialty TelecommunicationsCommunications Eutelsat SA is engaged in the provision of satellite communications. The company was founded on April 15, 1999 and is headquartered in Paris. France. | Specialty Telecommunications | Chief Executive Officer | |
GE Energy Power Conversion GmbH
GE Energy Power Conversion GmbH Electrical ProductsProducer Manufacturing GE Energy Power Conversion GmbH provides engineering, design, manufacturing, supply, commissioning and service of integrated electrical solutions including drive systems, control and automation systems. It focuses on offering drive systems, control, and automation systems. The company was founded in 1999 and is headquartered in Berlin, Germany. | Electrical Products | Chairman | |
European Satellite Operators Association
European Satellite Operators Association Miscellaneous Commercial ServicesCommercial Services European Satellite Operators Association engages in the provision of information communication services. It includes aviation. broadband, broadcasting, development, emergency communications, maritime, oil and gas, agriculture and fisheries, and mobile backhaul. It also offers artificial satellite such as operating in space; launching satellites; satellite orbits; green satellites; and latency communication networks. The company is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Chairman | |
Eutelsat International Ltd. | Director/Board Member | ||
FORVIA (EX-FAURECIA) | Auto Parts: OEM | Chairman | |
Inspection Générale des Finances | Chief Executive Officer | ||
Government of France | Sovereign | Human Resources Officer | |
Holdsat Mexico SAPI de CV | Director/Board Member | ||
Rhône-Poulenc Santé | Chief Executive Officer | ||
DBV TECHNOLOGIES | Pharmaceuticals: Major | Chairman |
Statistics
International
France | 18 |
United Kingdom | 13 |
Belgium | 7 |
United States | 6 |
Ireland | 3 |
Sectoral
Health Technology | 22 |
Communications | 8 |
Commercial Services | 6 |
Consumer Services | 5 |
Producer Manufacturing | 4 |
Operational
Director/Board Member | 110 |
Chairman | 52 |
Founder | 37 |
Corporate Officer/Principal | 29 |
Chief Executive Officer | 24 |
Most connected contacts
Insiders | |
---|---|
Philippe Pouletty | 51 |
Pierre Bastid | 29 |
Michel de Rosen | 28 |
Lawrence Steinman | 26 |
James Kuo | 24 |
Piers John Morgan | 18 |
Lena Elisabeth Svanberg | 16 |
Burkhard Blank | 10 |
Jean Combalbert | 8 |
Peter Collum | 7 |
Adrian Hepner | 7 |
Valérie Worrall | 3 |
Raj Thota | 3 |
Rodolphe Hajj | 1 |
Kenneth Lee | 1 |
- Stock Market
- Insiders
- Alexandre Berda
- Company connections